Regional anticoagulation with citrate: Expanding its indications

Critical Care Medicine

Volumn 39, Issue 2, 2011, Pages 399-400

  Morgera, Stanislao ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

liver failure; molecular adsorbent recirculation system; regional anticoagulation with citrate

Indexed keywords

CALCIUM ION; CITRIC ACID; HEPARIN;

ANTICOAGULATION; AREA UNDER THE CURVE; BLEEDING; CRITICALLY ILL PATIENT; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; EDITORIAL; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLIC ACIDOSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TREATMENT DURATION;

EID: 79251534733     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318205c500     Document Type: Editorial

References (16)

1. Mehta RL, McDonald BR, Aguilar MM, et al: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38:976-981
2. Hetzel GR, Schmitz M, Wissing H, et al: Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: A prospective randomized multicentre trial. Nephrol Dial Transplant 2010; In Press
3. Morgera S, Schneider M, Slowinski T, et al: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009; 37:2018-2024
4. Bö hler J, Schollmeyer P, Dressel B, et al: Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: Dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996: 7; 234-241.
5. Bos JC, Grooteman MP, van Houte AJ, et al: Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997; 12:1387-1393
6. Wexler IB, Pincus JB, Natelson S, et al: The fate of citrate in erythroblastic infants treated with exchange transfusion. J Clin Invest 1949; 28:474-481
7. Nowak MA, Campbell TE: Profound hypercalcemia in continuous veno-venous hemofiltration dialysis with trisodium citrate anticoagulation and hepatic failure. Clin Chem 1997; 43:412-413
8. Apsner R, Schwarzenhofer M, Derfler K, et al: Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997; 109:123-127
9. Meier-Kriesche HU, Gitomer J, Finkel K, et al: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29:748-752
10. Diaz J, Acosta F, Parrilla P, et al: Citrate intoxication and blood concentration of ionized calcium in liver transplantation. Transplant Proc 1994; 26:3669-3670
11. Marquez J, Martin D, Virji MA, et al: Cardiovascular depression secondary to ionic hypocalcemia during hepatic transplantation in humans. Anesthesiology 1986; 65:457-461
12. Kramer L, Bauer E, Joukhadar C, et al: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31:2450-2455
13. Hetzel GR, Taskaya G, Sucker C, et al: Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 2006; 48: 806-811
14. Wilkinson AH, Ash SR, Nissenson AR: Hemodiabsorption in treatment of hepatic failure. J Transpl Coord 1998; 1:43-50
15. Faybik P, Hetz H, Mitterer G, et al: Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 2011; 39:273-279
16. Faybik P, Bacher A, Kozek-Langenecker SA, et al: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: An observational study. Crit Care 2006; 10:R24